Evidence map›Paper›PMID 41743175›Full record

ArticleJCEM case reports2026

Postparathyroidectomy calciphylaxis in a patient with primary hyperparathyroidism: a rare complication.

Akriti Karki, Lina Alomari, Joy Halliday, Sherly Mathews, Asif Ali

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Akriti KarkiThe University of Buckingham Medical School, Buckingham MK18 1EG, UK.ORCID https://orcid.org/0009-0009-4700-6702
Lina AlomariDepartments of Endocrinology and Diabetes, Pathology and Intensive Care, Milton Keynes University Hospital, Milton Keynes MK6 5LD, UK.ORCID https://orcid.org/0009-0005-8635-6941
Joy HallidayDepartments of Endocrinology and Diabetes, Pathology and Intensive Care, Milton Keynes University Hospital, Milton Keynes MK6 5LD, UK.
Sherly MathewsDepartments of Endocrinology and Diabetes, Pathology and Intensive Care, Milton Keynes University Hospital, Milton Keynes MK6 5LD, UK.
Asif AliDepartments of Endocrinology and Diabetes, Pathology and Intensive Care, Milton Keynes University Hospital, Milton Keynes MK6 5LD, UK.ORCID https://orcid.org/0009-0005-8293-5663

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calciphylaxis, a rare and life-threatening condition involving calcification of small to medium-sized arterioles in subcutaneous tissue, leads to ischemia and necrosis. While typically seen in chronic kidney disease (CKD), a small proportion of cases can present without CKD, referred to as nonuremic calciphylaxis (NUC). NUC associated with primary hyperparathyroidism is rare with limited evidence-based management. A 41-year-old woman with no prior medical history presented with cardiac arrest due to severe hypercalcemia of 17.87 mg/dL (4.46 mmol/L) (normal reference range, 8.6-10.3 mg/dL; 2.2-2.6 mmol/L) and markedly elevated parathyroid hormone (PTH) levels. She required intensive care and extracorporeal membrane oxygenation (ECMO). Following stabilization, she underwent emergency parathyroidectomy for a parathyroid adenoma. During her prolonged recovery over 100 days, she developed painful necrotic skin lesions. Histopathology confirmed calciphylaxis. Management was conservative, involving wound care and analgesia, without surgical debridement. Her skin lesions resolved, and she has remained free of recurrence with stable calcium and PTH levels for more than 10 years. NUC following parathyroidectomy for primary hyperparathyroidism is rare. Multifactorial causes could contribute to the pathogenesis of calciphylaxis in our case, involving acute kidney injury, ECMO, and prolonged immobility. Early recognition and multidisciplinary management are crucial given the high mortality rate in calciphylaxis.

Indexed as

hypercalcaemianonuremic calciphylaxisprimary hyperparathyroidism

Identifiers

PMID41743175
PMCPMC12930472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.